What's Happening?
A report from OC&C Strategy Consultants indicates that the increasing use of GLP-1 drugs, which are primarily used for weight loss and diabetes management, is expected to cause a shift in the U.S. food and beverage market. The penetration rate of these
drugs is projected to rise from 12% to between 15% and 18% by 2031. This increase is anticipated to result in a 0.2% annual decrease in food and beverage demand volume. However, the composition of consumer purchases is expected to change, with a greater focus on protein, nutrient density, and fresh or functional food categories. The report highlights that current GLP-1 users are more focused on weight loss than diabetes, leading to changes in consumption patterns, such as increased fiber and vitamin intake. Additionally, there is a significant churn in the user base, with 60% of users discontinuing the drugs within six months, although many are likely to restart.
Why It's Important?
The shift in consumer behavior driven by GLP-1 drug use presents both challenges and opportunities for the U.S. food and beverage industry. Companies may need to adapt by offering products that align with the dietary preferences of GLP-1 users, such as those high in protein and fiber. This trend could lead to increased demand for nutrient-dense foods and a decline in indulgent and discretionary categories like alcohol and sweet snacks. As a result, businesses may need to innovate and reshape their product portfolios to meet changing consumer needs. The report suggests that companies like Danone are already responding by acquiring brands that align with these trends, such as Huel, a protein-focused company.
What's Next?
Food and beverage companies are likely to continue adjusting their strategies to cater to the evolving preferences of GLP-1 users. This may involve developing new products with value-added ingredients, pursuing acquisitions, and reshaping portfolios to emphasize nutrient-dense options. The industry could see increased innovation in smaller portion sizes and products with cleaner labels and stronger taste and texture. As companies navigate these changes, they will need to balance the trade-off between volume and the benefits offered to specific consumer groups. The competitive landscape may also shift as companies explore different paths to address the impact of GLP-1 use on consumer behavior.
